​
​

Albemarle (ALB) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

ALB Stock Forecast

Albemarle stock forecast is as follows: an average price target of $184.55 (represents a 78.26% upside from ALB’s last price of $103.53) and a rating consensus of 'Buy', based on 18 wall street analysts offering a 1-year stock forecast.

ALB Price Target

The average price target for Albemarle (ALB) is $184.55 based on 1-year price targets from 18 Wall Street analysts in the past 3 months, with a price target range of $308.00 to $90.00. This represents a potential 78.26% upside from ALB's last price of $103.53.

ALB Analyst Ratings

Buy

According to 18 Wall Street analysts, Albemarle's rating consensus is 'Buy'. The analyst rating breakdown for ALB stock is 0 'Strong Buy' (0.00%), 11 'Buy' (61.11%), 5 'Hold' (27.78%), 2 'Sell' (11.11%), and 0 'Strong Sell' (0.00%).

Albemarle Price Target by Analyst

DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Nov 13, 2024Andres Castanos-MollorBerenberg Bank$102.00$81.6524.92%-1.48%
Nov 12, 2024Aleksey YefremovKeyBanc$127.00$98.5628.85%22.67%
Sep 27, 2024Laurence AlexanderJefferies$120.00$96.0524.93%15.91%
Aug 16, 2024Joel JacksonBMO Capital$150.00$77.8192.78%44.89%
Aug 08, 2024Charles NeivertPiper Sandler$90.00$80.3911.95%-13.07%
Aug 06, 2024Arun ViswanathanRBC Capital$111.00$81.0536.95%7.22%
Aug 05, 2024Aleksey YefremovKeyBanc$132.00$83.8057.52%27.50%
Jul 31, 2024Andres Castanos-MollorBerenberg Bank$83.00$92.51-10.28%-19.83%
Jun 25, 2024Charles NeivertPiper Sandler$95.00$92.772.40%-8.24%
Jun 13, 2024Joshua SpectorUBS$124.00$112.6510.08%19.77%
Row per page
Go to

The latest Albemarle stock forecast, released on Nov 13, 2024 by Andres Castanos-Mollor from Berenberg Bank, set a price target of $102.00, which represents a 24.92% increase from the stock price at the time of the forecast ($81.65), and a -1.48% decrease from ALB last price ($103.53).

Albemarle Price Target by Period

1M3M12M
# Anlaysts2318
Avg Price Target$114.50$116.33$129.22
Last Closing Price$103.53$103.53$103.53
Upside/Downside10.60%12.36%24.81%

In the current month, the average price target of Albemarle stock is $114.50, according to 2 Wall Street analysts offering twelve months forecast. The average price target represents a 10.60% increase as opposed to Albemarle's last price of $103.53. This month's average price target is down -1.57% compared to last quarter, and down -11.39% compared to last year.

Analyst Ratings Upgrades/Downgrades

DateCompanyPrevious RatingNew RatingRating Change
Oct 07, 2024Wells FargoEqual-WeightEqual-WeightHold
Sep 27, 2024JefferiesBuyBuyHold
Aug 16, 2024BMO CapitalOutperformOutperformHold
Aug 08, 2024Piper SandlerUnderweightUnderweightHold
Aug 06, 2024RBC CapitalOutperformOutperformHold
Aug 05, 2024KeyBancOverweightOverweightHold
Jul 31, 2024Wells FargoSector PerformSector PerformHold
Jul 31, 2024UBSUnderperformUnderperformHold
Jul 17, 2024HSBC-HoldDowngrade
Jul 10, 2024Wells FargoSector PerformEqual-WeightDowngrade
Row per page
Go to

Albemarle's last stock rating was published by Wells Fargo on Oct 07, 2024. The company gave ALB a "Equal-Weight" rating, the same as its previous rate.

Albemarle Financial Forecast

Albemarle Revenue Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
Revenue-------------$2.31B$2.37B$2.58B$2.62B$2.09B$1.48B$1.13B$894.20M$830.57M$773.90M$829.29M$879.15M$746.87M$764.05M$738.85M$992.56M$879.75M
Avg Forecast$1.92B$1.54B$1.63B$1.48B$1.58B$1.44B$1.39B$1.28B$1.37B$1.37B$1.34B$1.29B$2.18B$2.52B$2.42B$2.71B$2.62B$2.22B$1.43B$1.04B$897.26M$765.09M$786.42M$758.48M$853.25M$734.69M$710.17M$762.58M$1.00B$882.41M
High Forecast$2.16B$1.73B$1.83B$1.66B$1.77B$1.62B$1.56B$1.29B$1.70B$1.38B$1.34B$1.29B$2.31B$2.91B$2.71B$3.04B$2.94B$2.22B$1.43B$1.04B$897.26M$765.09M$786.42M$758.48M$853.25M$734.69M$710.17M$762.58M$1.00B$882.41M
Low Forecast$1.68B$1.35B$1.43B$1.30B$1.38B$1.26B$1.22B$1.12B$1.18B$1.35B$1.34B$1.29B$2.10B$2.06B$2.12B$2.38B$2.30B$2.22B$1.43B$1.04B$897.26M$765.09M$786.42M$758.48M$853.25M$734.69M$710.17M$762.58M$1.00B$882.41M
# Analysts22221114115336168912778138891377986
Surprise %-------------0.92%0.98%0.95%1.00%0.94%1.04%1.09%1.00%1.09%0.98%1.09%1.03%1.02%1.08%0.97%0.99%1.00%

Albemarle's average Quarter revenue forecast for Dec 23 based on 6 analysts is $2.18B, with a low forecast of $2.10B, and a high forecast of $2.31B. ALB's average Quarter revenue forecast represents a -5.77% decrease compared to the company's last Quarter revenue of $2.31B (Sep 23).

Albemarle EBITDA Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts22221114115336168912778138891377986
EBITDA-------------$-140.01M$287.04M$1.27B$887.13M$976.66M$513.86M$402.45M$84.74M$-440.23M$600.16M$223.93M$155.46M$206.86M$176.75M$196.22M$164.45M$246.01M
Avg Forecast$472.27M$378.52M$400.05M$363.46M$387.39M$354.45M$341.08M$313.80M$335.55M$335.29M$327.84M$307.78M$534.57M$618.55M$593.45M$279.80M$88.36M$425.17M$273.00M$254.36M$171.65M$146.37M$150.45M$139.95M$163.23M$140.55M$135.86M$156.03M$191.91M$168.81M
High Forecast$529.92M$424.73M$448.88M$407.83M$434.68M$397.72M$382.71M$316.12M$417.72M$338.12M$327.84M$369.34M$567.25M$714.97M$665.89M$335.76M$106.03M$425.17M$273.00M$305.24M$171.65M$146.37M$150.45M$167.94M$163.23M$140.55M$135.86M$187.24M$191.91M$168.81M
Low Forecast$413.63M$331.53M$350.38M$318.34M$339.29M$310.45M$298.73M$274.84M$289.90M$332.46M$327.84M$246.23M$515.89M$505.69M$519.77M$223.84M$70.69M$425.17M$273.00M$203.49M$171.65M$146.37M$150.45M$111.96M$163.23M$140.55M$135.86M$124.83M$191.91M$168.81M
Surprise %--------------0.23%0.48%4.54%10.04%2.30%1.88%1.58%0.49%-3.01%3.99%1.60%0.95%1.47%1.30%1.26%0.86%1.46%

16 analysts predict ALB's average Quarter EBITDA for Sep 23 to be $618.55M, with a high of $714.97M and a low of $505.69M. This is 115.50% upper than Albemarle's previous annual EBITDA (Jun 23) of $287.04M.

Albemarle Net Income Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts22221114115336168912778138891377986
Net Income-------------$302.53M$650.04M$880.51M$838.99M$672.32M$312.44M$253.38M$-23.09M$-402.14M$424.60M$95.68M$58.53M$98.30M$85.62M$107.20M$90.39M$155.07M
Avg Forecast$180.64M$129.70M$122.19M$71.58M$53.12M$29.96M$3.67M$-38.37M$-77.47M$-51.58M$50.16M$182.08M$115.61M$441.09M$526.64M$165.52M$-3.99M$819.24M$365.44M$150.48M$117.12M$90.15M$98.56M$59.80M$129.20M$91.73M$86.69M$85.25M$204.77M$183.63M
High Forecast$209.31M$150.28M$141.58M$82.94M$61.55M$34.71M$4.26M$-22.57M$215.57M$-43.25M$50.18M$218.49M$188.01M$890.89M$610.22M$198.63M$-3.19M$819.24M$365.44M$180.57M$117.12M$90.15M$98.56M$71.76M$129.20M$91.73M$86.69M$102.30M$204.77M$183.63M
Low Forecast$151.48M$108.76M$102.47M$60.03M$44.55M$25.12M$3.08M$-54.17M$-319.99M$-59.76M$50.15M$145.66M$22.19M$236.34M$441.64M$132.42M$-4.78M$819.24M$365.44M$120.38M$117.12M$90.15M$98.56M$47.84M$129.20M$91.73M$86.69M$68.20M$204.77M$183.63M
Surprise %-------------0.69%1.23%5.32%-210.41%0.82%0.85%1.68%-0.20%-4.46%4.31%1.60%0.45%1.07%0.99%1.26%0.44%0.84%

Albemarle's average Quarter net income forecast for Dec 23 is $115.61M, with a range of $22.19M to $188.01M. ALB's average Quarter net income forecast represents a -61.79% decrease compared to the company's last Quarter net income of $302.53M (Sep 23).

Albemarle SG&A Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts22221114115336168912778138891377986
SG&A-------------$173.87M$397.07M$154.31M$148.16M$134.48M$128.94M$112.57M$123.30M$103.48M$121.52M$93.19M$124.91M$96.09M$106.95M$101.88M$185.16M$108.14M
Avg Forecast$225.37M$180.63M$190.90M$173.45M$184.86M$169.15M$162.76M$149.75M$160.13M$160.00M$156.45M$80.89M$255.10M$295.18M$283.20M$73.54M$128.57M$258.31M$165.85M$66.85M$104.28M$88.92M$91.40M$58.24M$99.17M$85.39M$82.54M$81.01M$116.59M$102.56M
High Forecast$252.88M$202.68M$214.21M$194.62M$207.43M$189.79M$182.63M$150.86M$199.34M$161.35M$156.45M$97.07M$270.69M$341.19M$317.77M$88.24M$154.28M$258.31M$165.85M$80.22M$104.28M$88.92M$91.40M$69.89M$99.17M$85.39M$82.54M$97.21M$116.59M$102.56M
Low Forecast$197.39M$158.21M$167.20M$151.91M$161.91M$148.15M$142.56M$131.16M$138.34M$158.65M$156.45M$64.71M$246.19M$241.32M$248.04M$58.83M$102.85M$258.31M$165.85M$53.48M$104.28M$88.92M$91.40M$46.59M$99.17M$85.39M$82.54M$64.81M$116.59M$102.56M
Surprise %-------------0.59%1.40%2.10%1.15%0.52%0.78%1.68%1.18%1.16%1.33%1.60%1.26%1.13%1.30%1.26%1.59%1.05%

Albemarle's average Quarter SG&A projection for Dec 23 is $255.10M, based on 6 Wall Street analysts, with a range of $246.19M to $270.69M. The forecast indicates a 46.72% rise compared to ALB last annual SG&A of $173.87M (Sep 23).

Albemarle EPS Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts22221114115336168912778138891377986
EPS-------------$2.58$5.54$7.51$7.16$5.74$2.67$2.16$-0.20$-3.44$3.63$0.85$0.55$0.92$0.81$1.01$0.85$1.46
Avg Forecast$1.54$1.10$1.04$0.61$0.45$0.25$0.03$-0.33$-0.66$-0.44$0.43$0.25$0.98$3.75$4.48$7.27$8.26$6.97$3.11$1.64$1.00$0.77$0.84$0.80$1.10$0.78$0.74$0.82$1.74$1.56
High Forecast$1.78$1.28$1.20$0.71$0.52$0.30$0.04$-0.19$1.83$-0.37$0.43$0.25$1.60$7.58$5.19$8.42$9.57$6.97$3.11$1.64$1.00$0.77$0.84$0.80$1.10$0.78$0.74$0.82$1.74$1.56
Low Forecast$1.29$0.93$0.87$0.51$0.38$0.21$0.03$-0.46$-2.72$-0.51$0.43$0.25$0.19$2.01$3.76$6.09$6.93$6.97$3.11$1.64$1.00$0.77$0.84$0.80$1.10$0.78$0.74$0.82$1.74$1.56
Surprise %-------------0.69%1.24%1.03%0.87%0.82%0.86%1.32%-0.20%-4.48%4.33%1.07%0.50%1.18%1.10%1.23%0.49%0.93%

According to 6 Wall Street analysts, Albemarle's projected average Quarter EPS for Dec 23 is $0.98, with a low estimate of $0.19 and a high estimate of $1.60. This represents a -61.88% decrease compared to ALB previous annual EPS of $2.58 (Sep 23).

Albemarle Peer Comparison by Price Target

TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
GEVOGevo$1.43$2.92104.20%Buy
ALBAlbemarle$103.53$184.5578.26%Buy
LTHMLivent$16.51$27.3365.54%Buy
PPGPPG Industries$122.53$160.6531.11%Buy
LYBLyondellBasell Industries$82.65$101.6522.99%Hold
SQMSociedad Química y Minera de Chile$38.14$45.7519.95%Buy
DDDuPont de Nemours$81.85$93.2913.98%Buy
ECLEcolab$245.24$253.253.27%Buy
APDAir Products and Chemicals$317.10$315.87-0.39%Buy
LINLinde$449.10$426.24-5.09%Buy
SHWSherwin-Williams Company$378.99$354.89-6.36%Buy

ALB Forecast FAQ

Is Albemarle a good buy?

Yes, according to 18 Wall Street analysts, Albemarle (ALB) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 11 'Buy' recommendations, accounting for 61.11% of ALB's total ratings.

What is ALB's price target?

Albemarle (ALB) average price target is $184.55 with a range of $90 to $308, implying a 78.26% from its last price of $103.53. The data is based on 18 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Albemarle stock go up soon?

According to Wall Street analysts' prediction for ALB stock, the company can go up by 78.26% (from the last price of $103.53 to the average price target of $184.55), up by 197.50% based on the highest stock price target, and down by -13.07% based on the lowest stock price target.

Can Albemarle stock reach $200?

ALB's highest twelve months analyst stock price target of $308 supports the claim that Albemarle can reach $200 in the near future.

What is Albemarle's current price target trend?

2 Wall Street analysts forecast a $114.5 price target for Albemarle (ALB) this month, up 10.60% from its last price of $103.53. Compared to the last 3 and 12 months, the average price target increased by 12.36% and increased by 24.81%, respectively.

What are Albemarle's analysts' financial forecasts?

Albemarle's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $5.69B (high $6.24B, low $4.98B), average EBITDA is $1.4B (high $1.53B, low $1.22B), average net income is $48.38M (high $77.95M, low $18.58M), average SG&A $666.52M (high $730.72M, low $583.77M), and average EPS is $0.412 (high $0.663, low $0.158). ALB's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $6.57B (high $7.38B, low $5.76B), average EBITDA is $1.61B (high $1.81B, low $1.41B), average net income is $504.11M (high $584.1M, low $422.74M), average SG&A $770.35M (high $864.39M, low $674.71M), and average EPS is $4.29 (high $4.97, low $3.6).

Did the ALB's actual financial results beat the analysts' financial forecasts?

Based on Albemarle's last annual report (Dec 2022), the company's revenue was $7.32B, beating the average analysts forecast of $7.31B by 0.19%. Apple's EBITDA was $2.87B, beating the average prediction of $1.04B by 175.31%. The company's net income was $2.04B, beating the average estimation of $1.33B by 53.46%. Apple's SG&A was $524.14M, missing the average forecast of $619.58M by -15.40%. Lastly, the company's EPS was $17.44, missing the average prediction of $19.98 by -12.70%. In terms of the last quarterly report (Sep 2023), Albemarle's revenue was $2.31B, missing the average analysts' forecast of $2.52B by -8.28%. The company's EBITDA was $-140M, missing the average prediction of $618.55M by -122.64%. Albemarle's net income was $302.53M, missing the average estimation of $441.09M by -31.41%. The company's SG&A was $173.87M, missing the average forecast of $295.18M by -41.10%. Lastly, the company's EPS was $2.58, missing the average prediction of $3.75 by -31.25%